Sphera Healthcare: Funding, Team & Investors | Startup Intros

Loading organizations...

Sphera Healthcare: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Mar 30, 2021	Immune-Onc Therapeutics	$73.0M Onc Therapeutics - Series B	Dave Chenn	Northern Light Venture Capital, Octagon Capital, The Leukemia & Lymphoma Society, Vivo Capital
Jan 1, 2021	Werewolf Therapeutics	$72.0M Series B	Derek DiRocco	RA Capital, Adage Capital Management, Arkin Bio Ventures, CaaS Capital Management, DC Investment Partners, Elise Wang, HBM Healthcare Investments, Longwood Fund, MPM Capital, Soleus Capital, Taiho Ventures, UPMC Enterprises
Aug 13, 2018	Orchard Therapeutics	$150.0M Series C	Elise Wang	Agent Capital, ArrowMark Partners, Cormorant Asset Management, Cowen Healthcare Investments, Driehaus Capital Management, Foresite Capital, Ghost Tree Capital Group, Medison Ventures, Perceptive Advisors, RA Capital Management, RTW Investments, Temasek, Venrock
Jun 1, 2017	Deciphera Pharmaceuticals	$52.0M Series C	Redmile Group, Sphera Healthcare, Viking Global Investors	New Leaf Venture Partners
Sep 1, 2015	Selecta Biosciences	$38.0M Series E	OrbiMed	5AM Ventures, Advent Life Sciences, ARCH Venture Partners, Atlas Venture, Flagship Ventures, NanoDimension, Polaris Partners, The Column Group, AJU IB Investment, Flagship Ventures, Leukon Investments, NanoDimension, Osage University Partners, Polaris Partners, Ridgeback Capital Investments, Rusnano, Sanofi Ventures
Aug 11, 2015	Ovid Therapeutics	$75.0M Series B	Fidelity Management & Research Company	Cormorant Asset Management, Cowen Private Investments, DoubleLine Equity Healthcare Fund, Jennison Associates, Redmile Group, Sanofi Ventures, Tekla Capital Management
Jul 1, 2015	GenSight Biologics	$36.0M Series B	—	Abingworth, HealthCap, Fidelity Management & Research Company, Jennison Associates, Perceptive Advisors
Mar 31, 2015	aTyr Pharma	$76.0M Series E	Srinivas Akkaraju	Deerfield Management, EcoR1 Capital, Federated Investors, Rock Springs Capital, T. Rowe Price Associates